Physiological studies in congenital heart disease. X. The physiological findings in 34 patients with isolated pulmonary valvular stenosis.

F. Maraist,R. Daley,A. Draper,R. Heimbecker,F. Dammann,R. Kieffer,J. T. King,C. Ferencz,R. Bing

Abstract:

What problem does this paper attempt to address?

Underreporting Supplements: A Case of Drug-induced Liver Injury Due to a Testosterone Booster

Ashna Manhas,Casey Genevieve Arnold,Allison Marie Bush

DOI: https://doi.org/10.1093/milmed/usae136

2024-04-30

Military Medicine

Abstract:ABSTRACT Acute liver injuries (ALIs) are caused by a wide range of etiologies, and determining the cause can often be challenging. Detailed history taking is essential in patients with liver injuries to promptly determine the underlying source of injury and for timely treatment and prognosis. A 27-year-old active duty man presented to the emergency department (ED) with jaundice. On medication reconciliation, he only reported taking acetaminophen for a recent upper respiratory infection. The patient had an ALI and was treated with N-acetyl cysteine for presumed acetaminophen toxicity. Initially, his liver-associated enzymes (LAEs) improved, but 2 weeks after discharge, he returned to the ED upon referral from ship medical for jaundice and worsening liver injury. Repeated query into the patient’s history revealed that he was using a testosterone booster supplement for 6 months preceding initial hospitalization. After evaluation of other etiologies for liver injury returned negative, drug-induced liver injury from the testosterone booster was determined to be the underlying etiology. With discontinuation of the supplement, his liver injury improved. Hepatotoxicity is a major concern in supplement use; however, it is largely underreported. Supplements are often not recognized or reported as medications by patients, leading to failure to identify them as potential toxicants. This case highlights the importance of including supplement education and questioning in the evaluation of ALI and maintaining a high index of suspicion when other common etiologies of liver disease are negative.

medicine, general & internal
Analysis of mutation of the plasma cholinesterase gene in a man who had died following a traffic accident.

A. Tsuji,H. Inoue,K. Kudo,N. Ikeda

DOI: https://doi.org/10.1016/J.FORSCIINT.2005.08.021

IF: 2.676

2006-06-02

Forensic Science International

Abstract:
Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia

Emily Nash,Amanda Nicoll,Nicholas Batt,Jacob George,Varan Perananthan,David Prince,Michael Wallace,Paul Gow,Karl Vaz,Shivakumar Chitturi,Joan Ericka Flores,Alicia Braund,Mark Bonnichsen,Stephen Riordan,Jeremy Humphris,Tuan Duong,Catriona McKenzie,Ken Liu,Simone I. Strasser

DOI: https://doi.org/10.1111/apt.17906

IF: 9.524

2024-02-20

Alimentary Pharmacology & Therapeutics

Abstract:Liver injury is an important consideration of these drugs. Prognosis with supportive care is good, with normalisation of liver biochemistry the most likely outcome, although hospitalisation may be required and, rarely, liver transplantation. A detailed drug and dietary supplement history is important in elucidating causes of DILI. Summary Background Reports of DILI due to herbal and dietary supplements have been increasing over time. Aims To characterise clinical, laboratory and histopathological phenotypes and outcomes of drug‐induced liver injury (DILI) due to anabolic‐androgenic steroids (AAS), selective androgen receptor modulators (SARMs), and bodybuilding supplements (BBS) in Australia. Methods Retrospective case series. Patients presented to nine Australian tertiary hospitals, 2017–2023. DILI was defined biochemically and patients were included if their treating physician attributed DILI to preceding use of AAS, SARMs or BBS. Primary endpoint was time to normalisation of liver biochemistry. Secondary endpoints were hospitalisation for investigation or management of DILI, death attributable to liver injury, and liver transplantation. Results Twenty‐three cases of DILI were identified, involving 40 drugs: 18 AAS, 14 SARMs and eight BBS. Patients were predominantly male (22/23), with median age 30 years (IQR 26–42). Most were symptomatic (21/23). Median latency of onset was 58 days (IQR 28–112 days) from drug commencement. Most patients (17/23) were admitted to hospital. Based on updated Roussel Uclaf Causality Assessment Method, DILI was possible in 17/23, probable in 2/23 and unlikely in 4/23. Median time to normalisation of liver biochemistry was 175 days (IQR 70–292 days) from presentation. Three (3/23) were treated with corticosteroids, 14/23 were treated for itch, and one (1/23) underwent liver transplantation. There were no deaths. Conclusions The prognosis of DILI from AAS, SARMs and BBS is good although liver transplantation may rarely be required. A detailed drug history is important in uncovering DILI due to these supplements.

pharmacology & pharmacy,gastroenterology & hepatology
Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature

Robin Daniel Abeles,Matthew Foxton,Shahid Khan,Robert Goldin,Belinda Smith,Mark R Thursz,Suman Verma

DOI: https://doi.org/10.1136/bmjgast-2020-000549

Abstract:Background: Anabolic androgenic steroids (AAS) usage is widespread and increasing. AAS drug-induced liver injury (DILI) is recognised but its clinical course and management is poorly described. We report 2 cases of AAS DILI with associated renal dysfunction, managed successfully with oral corticosteroids. Methods: A comprehensive review identified 50 further cases to characterise the clinical and biochemical course. Causality grading was calculated using the updated Roussel Uclaf Causality Assessment Method (RUCAM) score. Data are presented as median values. Results: The most common AAS taken was methyldrostanolone. Patients commonly present with jaundice and pruritus but may exhibit other constitutional symptoms. Patients presented 56 days after starting, and bilirubin peaked 28 days after stopping, AAS. Causality assessment was 'unlikely' in 1 (2%), 'possible' in 31 (60%) and 'probable' in 20 (38%). Peak values were: bilirubin 705 μmol/L, alanine transaminase 125 U/L, aspartate transaminase 71 U/L, alkaline phosphatase 262 U/L, gamma-glutamyl transferase 52 U/L, international normalised ratio 1.1. Liver biopsies showed 'bland' canalicular cholestasis. 43% of patients developed kidney injury (peak creatinine 225 μmol/L). Therapies included antipruritics, ursodeoxycholic acid and corticosteroids. No patients died or required liver transplantation. Conclusions: Physicians are likely to encounter AAS DILI. Causality assessment using the updated RUCAM should be performed but defining indications and proving efficacy for therapies remains challenging.
S4554 Falling Through The Cracks: A Case Of Cholestatic Injury With Supratherapeutic Testosterone Supplementation

Mikaela Nikkola Jara-Tantoco,Nisa Mohammed,Sana Abbas,Salvatore Mignano,Richard Kalman

DOI: https://doi.org/10.14309/01.ajg.0001047584.26822.30

2024-10-26

The American Journal of Gastroenterology

Abstract:Drug induced liver injury (DILI) is an adverse reaction to an ingested drug or supplement. Anabolic androgenic steroids (AAS) have been associated with cholestatic DILI. Many individuals use this without a prescription. While patient education is important with the growing use of supplements, it may not be enough with patients who have difficulty navigating the healthcare system.

gastroenterology & hepatology
LGD-4033 and a Case of Drug-Induced Liver Injury: Exploring the Clinical Implications of Off-Label Selective Androgen Receptor Modulator Use in Healthy Adults

Harrison Labban,Brittany Kwait,Awais Paracha,Mohammed Islam,Dolly O Kim

DOI: https://doi.org/10.7759/cureus.69601

2024-09-17

Cureus

Abstract:Selective androgen receptor modulators (SARMs), designed to treat conditions such as muscle wasting and osteoporosis, are widely used among healthy adults seeking muscle hypertrophy and enhanced athletic performance, despite a lack of Food and Drug Administration (FDA) approval. This trend may be driven by the misconception that SARMs are safer alternatives to anabolic steroids. However, SARMs such as LGD-4033 (Ligandrol) are associated with significant adverse effects, including hepatotoxicity, cardiovascular complications, endocrine disturbances, and psychiatric symptoms. This report examines the clinical implications of off-label SARM use, focusing on a case of drug-induced liver injury (DILI) in a 52-year-old male. The patient presented with pruritic jaundice, significant weight loss, and elevated liver enzymes following three months of high-dose LGD-4033 use. A diagnostic workup ruled out other potential causes of liver injury, implicating SARM use as the likely etiology. This case underscores the necessity for heightened clinical vigilance, early diagnosis, and prompt intervention to mitigate serious health outcomes associated with SARM misuse.
Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review

Alex K. Bonnecaze,Thomas O’Connor,Cynthia A. Burns

DOI: https://doi.org/10.1007/s11606-021-06751-3

IF: 5.7

2021-05-04

Journal of General Internal Medicine

Abstract:Anabolic androgenic steroid (AAS) and performance-enhancing drug (PED) use is a prevalent medical issue, especially among men, with an estimated 2.9–4 million Americans using AAS in their lifetime. Prior studies of AAS use reveal an association with polycythemia, dyslipidemia, infertility, hypertension, left ventricular hypertrophy, and multiple behavioral disorders. AAS withdrawal syndrome, a state of depression, anhedonia, and sexual dysfunction after discontinuing AAS use, is a common barrier to successful cessation. Clinical resources for these patients and training of physicians on management of the patient using AAS are limited. Many men are hesitant to seek traditional medical care due to fear of judgment and lack of confidence in physician knowledge base regarding AAS. While proposed approaches to weaning patients off AAS are published, guidance on harm reduction for actively using patients remains sparse. Medical education regarding the management of AAS use disorder is paramount to improving care of this currently underserved patient population. Management of these patients must be non-judgmental and focus on patient education, harm reduction, and support for cessation. The approach to harm reduction should be guided by the specific AAS/PEDs used.

medicine, general & internal,health care sciences & services
Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review

Tomas Koller,Petra Vrbova,Iveta Meciarova,Pavol Molcan,Michal Smitka,Svetlana Adamcova Selcanova,Lubomir Skladany

DOI: https://doi.org/10.12998/wjcc.v9.i16.4062

2021-06-06

World Journal of Clinical Cases

Abstract:BACKGROUND: Muscle growth promoters are being developed for the treatment of disease-induced loss of muscle mass. Ligandrol and ostarine are selective androgen receptor modulators (SARMs) with a non-steroidal structure and a presumably more favorable side effect profile. In recent years, these substances with or without "post-cycle therapy" (PCT) are often misused by amateur athletes aiming to promote muscle growth. At the same time, reports on their toxic effects on organ systems are emerging.CASE SUMMARY: We report two cases of liver injury in young men who used ligandrol and/or ostarine for a few weeks followed by the use of substances for PCT. Acute liver injury occurred in both cases after stopping SARMs while on PCT. The clinical picture was dominated by jaundice and fatigue. The biochemical pattern showed a mixed type of injury with normal alkaline phosphatase and high concentrations of bilirubin and serum bile acids. Histological evidence showed predominantly cholestatic injury with canalicular bile plugs, ductopenia, and mild hepatocellular damage without significant fibrosis. The patients recovered from the condition after 3 mo. The off target effects of SARMs were likely idiosyncratic, but our report highlights the yet unrecognized effects of other toxic substances used for PCT, supra-therapeutic doses, and the complete absence of monitoring for adverse effects.CONCLUSION: Among muscle-building amateur athletes, SARMs (ligandrol or ostarine) and/or substances in PCT may cause cholestatic liver injury with prolonged recovery.

medicine, general & internal
Mutational Analysis of the Mitochondrial Copper Metallochaperone Cox17*

D. Heaton,T. Nittis,C. Srinivasan,D. Winge

DOI: https://doi.org/10.1074/JBC.M006639200

IF: 5.485

2000-12-01

Journal of Biological Chemistry

Abstract:The copper metallochaperone Cox17 is proposed to shuttle Cu(I) ions to the mitochondrion for the assembly of cytochromec oxidase. The Cu(I) ions are liganded by cysteinyl thiolates. Mutational analysis on the yeast Cox17 reveals three of the seven cysteinyl residues to be critical for Cox17 function, and these three residues are present in a Cys-Cys-Xaa-Cys sequence motif. Single substitution of any of these three cysteines with serines results in a nonfunctional cytochrome oxidase complex. Cells harboring such a mutation fail to grow on nonfermentable carbon sources and have no cytochrome c oxidase activity in isolated mitochondria. Wild-type Cox17 purified as untagged protein binds three Cu(I) ions/molecule. Mutant proteins lacking only one of these critical Cys residues retain the ability to bind three Cu(I) ions and are imported within the mitochondria. In contrast, Cox17 molecules with a double Cys → Ser mutation exhibit no Cu(I) binding but are still localized to the mitochondria. Thus, mitochondrial uptake of Cox17 is not restricted to the Cu(I) conformer of Cox17. COX17 was originally cloned by virtue of complementation of a mutant containing a nonfunctional Cys → Tyr substitution at codon 57. The mutant C57Y Cox17 fails to accumulate within the mitochondria but retains the ability to bind three Cu(I) ions. A C57S Cox17 variant is functional, and a quadruple Cox17 mutant with C16S/C36S/C47S/C57S substitutions binds three Cu(I) ions. Thus, only three cysteinyl residues are important for the ligation of three Cu(I) ions. A novel mode of Cu(I) binding is predicted.
Image Decompositions

M. Tappen

DOI: https://doi.org/10.1007/978-0-387-31439-6_549

Abstract:
Early functions of the genome of herpesvirus. V. Serological analysis of "immediate-early" proteins.

T. Ben‐Porat,M. Kervina,A. Kaplan

DOI: https://doi.org/10.1016/0042-6822(75)90041-0

IF: 3.513

1975-06-01

Virology

Abstract:
S4490 From Lean to Mean: A Case Report of Severe Hepatoxicity Linked to Animal Cuts, a Fat Burner Supplement

Ivana Martos,Muhammad A. Mansoor,Pablo Santander,Jared Magee

DOI: https://doi.org/10.14309/01.ajg.0001047328.72573.b3

2024-10-26

The American Journal of Gastroenterology

Abstract:A significant portion of the US population uses dietary supplements, including fat burners, with military service members showing higher usage rates compared to civilians. Fat burner supplements lack rigorous scientific studies supporting their efficacy and safety especially in the context of their use amongst military personnel. This case highlights the hepatotoxic effect of a fat burner supplement "Animal Cuts" containing Centella asiatica .

gastroenterology & hepatology
Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions

Eberhard Nieschlag,Elena Vorona

DOI: https://doi.org/10.1007/s11154-015-9320-5

2015-09-01

Reviews in Endocrine and Metabolic Disorders

Abstract:Since the 1970s anabolic androgenic steroids (AAS) have been abused at ever increasing rates in competitive athletics, in recreational sports and in bodybuilding. Exceedingly high doses are often consumed over long periods, in particular by bodybuilders, causing acute or chronic adverse side effects frequently complicated by additional polypharmacy. This review summarizes side effects on non-reproductive organs and functions; effects on male and female reproduction have been recently reviewed in a parallel paper. Among the most striking AAS side effects are increases in haematocrit and coagulation causing thromboembolism, intracardiac thrombosis and stroke as well as other cardiac disturbances including arrhythmias, cardiomyopathies and possibly sudden death. 17α-alkylated AAS are liver toxic leading to cholestasis, peliosis, adenomas and carcinomas. Hyperbilirubinaemia can cause cholemic nephrosis and kidney failure. AAS abuse may induce exaggerated self-confidence, reckless behavior, aggressiveness and psychotic symptoms. AAS withdrawal may be accompanied by depression and suicidal intentions. Since AAS abuse is not or only reluctantly admitted physicians should be aware of the multitude of serious side effects when confronted with unclear symptoms,

endocrinology & metabolism
Severe Cardiac and Metabolic Pathology Induced by Steroid Abuse in a Young Individual

Adrian Tirla,Cosmin Mihai Vesa,Simona Cavalu

DOI: https://doi.org/10.3390/diagnostics11081313

2021-07-21

Abstract:Androgenic-Anabolic Steroids (AAS) abuse is known to play an important role in causing the systemic inflammatory response and multiple-organ dysfunction in healthy individuals. Although many of the undesirable effects of steroid abuse have been reported, at present, little is known about the effect of anabolic supplements and the correlation between cardiac and metabolic pathology. This paper presents a case of a 25 year old patient with a complex medical history after 6 months of steroid administration. Myocardial infraction, dyslipidemia, obesity, hyperuricemia, secondary diabetes, and chronic renal disease were identified after clinical and para-clinical examinations. The particularities of this case were interpreted in the context of a literature review, highlighting the effect of multi-organ damage as a result of the uncontrolled use of anabolic steroid supplements.
Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men

Alex K. Bonnecaze,Thomas O’Connor,Joseph A. Aloi

DOI: https://doi.org/10.1177/1557988320966536

2020-11-01

Abstract:Additional characterization of patients using anabolic androgenic steroids (AAS) is needed to improve harm reduction and cessation resources for patients. Our group sought to expand upon the currently limited data regarding AAS use by performing a web-based survey assessing experiences of males using AAS. Participants included men over the age of 18 with history of AAS use within the past 5 years. Data were collected between August 2019 and April 2020. Primary outcome measures included age when starting AAS, dose of AAS, motivations for use, experiences with health-care professionals, and rate of successful cessation. The survey was accessed 3640 times, resulting in 2385 completed surveys meeting the inclusion criteria (68.93% participation rate). Average participant age was 31.69 ± 10.09 years. Over half of respondents were from the United States ( n = 1271, 53.3%). Motives to use AAS included improving appearance ( n = 1959, 82.2%), strength gain ( n = 1192, 50%), and self-esteem/body image issues ( n = 712, 29.87%). Participants rated physicians poorly, regarding knowledge of AAS (4.08 ± 2.23). Most participants did not reveal AAS use to their health-care providers ( n = 1338, 56.1%); of those that did, 55.30% ( n = 579) reported feeling discriminated against for their use. Of 46.16% ( n = 1101) attempting AAS cessation, 60.22% ( n = 663) were unsuccessful. Challenges in the management of AAS use include early onset of use, supraphysiologic doses used, and frequently present body image disorders stress. Distrust of health-care providers, poor cessation rates, and lack of physician training further exacerbate this. These findings should serve to reinforce previous calls to action for further research on the treatment of AAS use disorder.
The Assessment of Liver Function Test and Fertility Hormones in Saudi Athletes Using Anabolic Androgenic Steroids

Shatha Jambi,Ahmed Mirza,Torki Zughaibi,Haitham Khalil,Anwar Borai

DOI: https://doi.org/10.1016/j.jsps.2024.101954

IF: 4.562

2024-01-11

Saudi Pharmaceutical Journal

Abstract:BACKGROUND A growing number of athletes are using synthetic anabolic-androgenic steroids (AAS), comprised of testosterone and other derivatives, to enhance athletic performance and muscle mass. Over the years, numerous reports elucidated the side effects of the illegal use of AAS, such as infertility, and liver disorders. The effect of AAS on the hepatic and reproductive systems in Saudi athletes has not yet been studied. Therefore, this study examined the liver function and sex hormone parameters of AAS users as compared to non-users. METHODS Fasting blood samples were collected from 16 male Saudi athletes, 10 AAS-users (cases) and 6 non-users (controls) to measure liver function tests (ALT, AST, GGT, ALP, total protein, albumin, direct and total bilirubin) and muscle enzymes (CK, LDH), Fertility hormones (LH, FSH, total testosterone, estradiol, and prolactin) were included also. Furthermore, a self-reported questionnaire was obtained to identify the type of AAS used, the dosage, and the length of the course before sample collection. RESULTS The results show a statistically significant increase in ALT ( P < 0.001), AST ( P < 0.001), CK ( P < 0 .05), and a significant decrease ( P < 0.05) in albumin ( P < 0.001) and total bilirubin levels ( P < 0.01) in AAS-users. Total testosterone increased significantly among AAS ( P < 0 .05), along with a significant decrease in LH ( P < 0 .01), and FSH ( P < 0.001) levels, while serum prolactin and estradiol levels were significantly increased ( P < 0.05). CONCLUSION AAS can enhance physical performance and appearance, its potential adverse effects on the hepatic and reproductive systems necessitate careful consideration. Our research demonstrates an increase in the liver-specific enzyme ALT in AAS users relative to non-users and the possibility that short-term AAS usage increases the risk of liver injury.

pharmacology & pharmacy
Metabolic and hormonal dysfunction in asymptomatic patient using selective androgen receptor modulators: a case report

Brian Malave

DOI: https://doi.org/10.1186/s42269-023-00989-z

2023-01-30

Bulletin of the National Research Centre

Abstract:Abstract Background Selective androgen receptor modulators (SARMs) are becoming increasingly common amongst athletes and the general population, but their side effect profile in human subjects at recreational doses is understudied. Case presentation A 27-year-old asymptomatic male weightlifter presented for an annual physical exam and was coincidentally found to have an abnormal lipid panel, which the patient believed to be due to recreational SARMs (LGD-4033 and S-23) usage. Further work-up revealed elevated liver enzymes suggestive of hepatocellular injury and suppression of the pituitary–gonadal axis. Lipids, hepatic function, and hormones returned to baseline after cessation of SARMs. Conclusions This is the first case report on how SARMs may impact LDL, cause hepatocellular rather than cholestatic liver injury, and alter health markers despite complete lack of symptoms. It is also the first case report on the potential negative effects of the SARM S-23.
An application of ICA-based detection to OFDM-IDMA system

E. Meftah,A. Anou,M. Bensebti

DOI: https://doi.org/10.1109/ICM.2012.6471362

2012-12-01

Abstract:In this paper, an ICA-based blind multiuser detection approach for OFDM-IDMA system is presented. ICA is a signal processing technique that aims to detect a set of unknown mutually independent source signals from their observed mixtures without prior knowledge of the mixing coefficients. The proposed algorithm is applied as post processors attached to IDMA receiver. In this study, the performance of the proposed detector is compared to the conventional turbo type iterative OFDM-IDMA multiuser detector in which chip interleavers are the only means of user separation. Validity and performances of the described approach are demonstrated by numerical simulations based on examining the bit error rate (BER) criterion in the quasi-static Rayleigh fading channel.
Neuropsychiatric and Behavioral Involvement in AAS Abusers. A Literature Review

Giuseppe Bertozzi,Monica Salerno,Cristoforo Pomara,Francesco Sessa

DOI: https://doi.org/10.3390/medicina55070396

2019-07-22

Medicina

Abstract:Background and Objectives: Anabolic androgenic steroids (AASs) are a complex group of molecules that include both steroidal androgens and synthetic compounds, derived from testosterone. AASs are commonly used to support pharmacological therapy in cases of primary or secondary hypogonadism, major burns, and neoplastic cachexia. Their prolonged and supra-physiological consumption can provoke several adverse effects on various organs and systems. Among these, the physiopathological mechanisms that induce neuropsychiatric disorders related to AAS abuse are poorly known. For this reason, the proposed review aims to retrace the pathway of action of testosterone to focus on the effects on the central nervous system and specifically highlight the effects of AASs on neuropsychiatric and behavioral functions, as well as on lifestyle. Materials and Methods: This review was conducted using PubMed and Google Scholar databases. On these database websites, we searched for articles from 1 January 1980 to March 2019 using the key terms: “AAS,” “Anabolic Androgenic Steroids,” “brain,” and “neurology.” Results: The use of AASs through self-administration yields circulating androgens levels, inducing neuron apoptosis, which is linked to thinner cortex and, in general, less cortical volume. The same alterations affect the putamen. These differences were more evident when correlated with longer use. From a functional point of view, prolonged AAS consumption seemed to be related to lower connectivity between amygdala and frontal, striatal, limbic, hippocampal and visual cortical areas. On the other hand, AAS use seems to negatively condition the positive effects of the sport exercise, reducing its important anti-apoptotic and pro-proliferative functions on the hippocampus, implicated in anxiolytic control. Conclusion: This review clarifies the major aspects of the side effects related to AAS use/abuse highlighting the complex mechanisms on neuropsychiatric and cognitive pathological alterations and also the emotional and behavioral dysfunctions.
The sexual impact of androgenic anabolic steroid abuse an understudied phenomena

Kole P. Akula,Lucien R. McBeth,Matthias D. Hofer

DOI: https://doi.org/10.1038/s41443-024-00879-6

2024-04-10

International Journal of Impotence Research

Abstract:Anabolic steroids are becoming increasingly more common even amongst non-athletes. A recent meta analysis estimates 6.4% of men and 1.3% of women have used androgenic compounds to aid in sports or muscle building [1]. Although these compounds are being increasingly commonly used, only 37% of patients seek advice from health care providers in regard to their steroid use [2]. Many physicians will encounter the impacts of androgenic compounds before their patients report use. Androgenic anabolic steroids (AAS) have been shown to increase libido and sexual function in humans when patients are hypogonadal [3]. There is little evidence exploring the impact of supraphysiologic doses in humans. We have summarized the current literature surrounding AAS abusers and seek to encourage further study of this population.

urology & nephrology

Physiological studies in congenital heart disease. X. The physiological findings in 34 patients with isolated pulmonary valvular stenosis.

Underreporting Supplements: A Case of Drug-induced Liver Injury Due to a Testosterone Booster

Analysis of mutation of the plasma cholinesterase gene in a man who had died following a traffic accident.

Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia

Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature

S4554 Falling Through The Cracks: A Case Of Cholestatic Injury With Supratherapeutic Testosterone Supplementation

LGD-4033 and a Case of Drug-Induced Liver Injury: Exploring the Clinical Implications of Off-Label Selective Androgen Receptor Modulator Use in Healthy Adults

Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review

Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review

Mutational Analysis of the Mitochondrial Copper Metallochaperone Cox17*

Image Decompositions

Early functions of the genome of herpesvirus. V. Serological analysis of "immediate-early" proteins.

S4490 From Lean to Mean: A Case Report of Severe Hepatoxicity Linked to Animal Cuts, a Fat Burner Supplement

Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions

Severe Cardiac and Metabolic Pathology Induced by Steroid Abuse in a Young Individual

Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men

The Assessment of Liver Function Test and Fertility Hormones in Saudi Athletes Using Anabolic Androgenic Steroids

Metabolic and hormonal dysfunction in asymptomatic patient using selective androgen receptor modulators: a case report

An application of ICA-based detection to OFDM-IDMA system

Neuropsychiatric and Behavioral Involvement in AAS Abusers. A Literature Review

The sexual impact of androgenic anabolic steroid abuse an understudied phenomena